Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
43 hedge funds and large institutions have $773M invested in Omega Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$497M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$80.6M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$50.8M |
| 4 |
AG
Artal Group
Luxembourg
|
+$43.6M |
| 5 |
CA
CHI Advisors
New York
|
+$20.3M |
Top Sellers
OMGA Hedge Fund Activity: Q3 2021 in Review
43 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q3 2021, worth a combined $773M.
Buyers outnumbered sellers: 43 funds opened new OMGA positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Flagship Pioneering, opening a new position worth an estimated $497M.
- 43 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $773M of Omega Therapeutics, Inc. Common Stock stock for Q3 2021.
- 43 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q3 2021 and 0 closed out, a net change of +43 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q3 2021 was Flagship Pioneering, an estimated $497M added.
Based on aggregated 13F filings for Q3 2021.